Showing 5,001 - 5,020 results of 6,597 for search 'Hejaz~', query time: 2.06s Refine Results
  1. 5001

    GC-MS Analysis, Antimicrobial and Antioxidant Activities of Extracts of the Aerial Parts of <i>Conyza sumatrensis</i> by Olapeju O Aiyelaagbe, Stephen O Oguntoye, Abdulmumeen A Hamid, Adebola M Ogundare, David B Ojo, Ajibola Ajao, Nurudeen O Owolabi

    Published 2016-05-01
    “…METHODS: The aerial parts of C. sumatrensis were air dried, weighed and exhaustively extracted with hexane, ethyl acetate and methanol successively. The crude extracts were screened for metabolites.  …”
    Get full text
    Article
  2. 5002

    GC-MS Analysis, Antimicrobial and Antioxidant Activities of Extracts of the Aerial Parts of <i>Conyza sumatrensis</i> by Olapeju O Aiyelaagbe, Stephen O Oguntoye, Abdulmumeen A Hamid, Adebola M Ogundare, David B Ojo, Ajibola Ajao, Nurudeen O Owolabi

    Published 2016-05-01
    “…METHODS: The aerial parts of C. sumatrensis were air dried, weighed and exhaustively extracted with hexane, ethyl acetate and methanol successively. The crude extracts were screened for metabolites.  …”
    Get full text
    Article
  3. 5003

    Evaluation of Association of Oral Bacterial Profile with HBV and HCV Infection and T Lymphocyte Level in HIV-Positive Patients by Fatemeh Lavaee, Farzan Modarresi, Samira Amookhteh, Mohammad Amin Amiri

    Published 2022-01-01
    “…The correlation of bacterial prevalence with hepatitis B and C was evaluated by chi-square test. …”
    Get full text
    Article
  4. 5004

    The immunoregulatory effects of scoparone on immune-mediated inflammatory diseases by Feifei Qiu, Jingru Lin, Xiaofei Huang, Bin Yang, Weihui Lu, Weihui Lu, Zhenhua Dai, Zhenhua Dai

    Published 2025-01-01
    “…., but also provides a comprehensive summary of its therapeutic effects on hepatic diseases, including non-alcoholic steatohepatitis, fulminant hepatic failure and hepatic fibrosis. …”
    Get full text
    Article
  5. 5005

    Hyperbilirubinemia: Does It Matter? by Lajos Okolicsanyi, Giulia Martina Cavestro, Claudia Guatti-Zuliani

    Published 1999-01-01
    “…Serum bilirubin concentrations are increased in several hematological and hepatic disorders; however, hyperbilirubinemia, often of familial origin, may occur without overt signs of hemolysis or evident liver disease. …”
    Get full text
    Article
  6. 5006
  7. 5007

    Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon’s Perspective! by Kelly J. Lafaro, Panayota Roumanis, Aram N. Demirjian, Chandana Lall, David K. Imagawa

    Published 2013-01-01
    “…Adequate resection of hepatic metastases is the only chance for a cure in a subset of patients, and five-year survival increases to 35% with complete resection. …”
    Get full text
    Article
  8. 5008

    Low viral persistence of an immunological model by Suqi Ma

    Published 2012-09-01
    “…Hepatitis B virus can persist at very low levels in the body in the face of host immunity, and reactive during immunosuppression and sustain the immunological memory to lead to the possible state of 'infection immunity'. …”
    Get full text
    Article
  9. 5009

    Standardization Study of Ghritas by D. Shaila, M. K. Santosh, T. Chandrakumar, I. Sanjeeva Rao

    Published 2004-01-01
    “…Qualitative analysis of alcoholic extracts of all the four ghritas shows the presence of glycosides and hexane extracts shows the presence of glycosides and steroids. …”
    Get full text
    Article
  10. 5010

    Gastroduodenal artery aneurysm degeneration after coiling necessitating open repair by Madeleine Carroll, MD, Deena B. Chihade, MD, Thomas J. Vandermeer, MD, Anthony Feghali, MD

    Published 2025-02-01
    “…His 12-month scan revealed aneurysmal growth from 5 cm to 7.5 cm involving the hepatic confluence. He underwent successful open aneurysm resection and primary anastomosis of the hepatic artery. …”
    Get full text
    Article
  11. 5011

    Liver Fibrosis and Mechanisms of the Protective Action of Medicinal Plants Targeting Inflammation and the Immune Response by Florent Duval, Jorge E. Moreno-Cuevas, María Teresa González-Garza, Carmen Maldonado-Bernal, Delia Elva Cruz-Vega

    Published 2015-01-01
    “…Inflammation is a central feature of liver fibrosis as suggested by its role in the activation of hepatic stellate cells leading to extracellular matrix deposition. …”
    Get full text
    Article
  12. 5012

    Caroli's Disease: Current Knowledge of Its Biliary Pathogenesis Obtained from an Orthologous Rat Model by Yasunori Sato, Xiang Shan Ren, Yasuni Nakanuma

    Published 2012-01-01
    “…Caroli's disease belongs to a group of hepatic fibropolycystic diseases and is a hepatic manifestation of autosomal recessive polycystic kidney disease (ARPKD). …”
    Get full text
    Article
  13. 5013

    Safe Resection of Renal Cell Carcinoma with Liver Invasion Using Liver Hanging Technique Supported by Preoperative Portal Vein Embolization by Masato Fujii, Toshio Kamimura, Hiromasa Tsukino, Eiji Furukoji, Tatefumi Sakae, Koichi Yano, Naoya Imamura, Shoichiro Mukai, Atsushi Nanashima, Toshiyuki Kamoto

    Published 2018-01-01
    “…The patient recovered without postoperative hepatic or urinary complications and has remained free of local recurrence and any de novo metastasis for 18 months.…”
    Get full text
    Article
  14. 5014

    Perioperative treatment with cilostazol reverses steatosis and improves liver regeneration after major hepatectomy in a steatotic rat model by Sebastian Holländer, Maximilian von Heesen, Gereon Gäbelein, Julie Mercier, Matthias W. Laschke, Michael D. Menger, Matthias Glanemann, Antonios E. Spiliotis

    Published 2025-01-01
    “…Abstract Cilostazol has previously been shown to reduce liver steatosis and enhance hepatic perfusion. We investigated the effects of cilostazol after major hepatectomy in a steatotic rat model. …”
    Get full text
    Article
  15. 5015

    Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease by Shi-Chun Lu, Tao Jiang, Wei Lai, Yuan Liu, Jing Zhang, Dao-Bing Zeng, Chuan-Yun Li, Meng-Long Wang, Dong-Dong Lin, Yue Zhu, You-Ping Li, Ning Li

    Published 2014-01-01
    “…The aim of this study was to establish a hepatitis B virus (HBV) vaccination protocol among orthotopic liver transplantation (OLT) recipients under the coverage of a low-dose hepatitis B immunoglobulin (HBIG) combined with an antiviral agent prophylaxis protocol. …”
    Get full text
    Article
  16. 5016

    Barriers Preventing Liver Transplantation in Canadians with HIV Infection – Perceptions of HIV Specialists by Curtis L Cooper, Joanne DeForest, John Gill, Richard Lalonde, on behalf of the Canadian HIV Trials Network (CTN) Co-Infection Core Group

    Published 2007-01-01
    “…A median 20% of the nearly 12,700 HIV patients followed at these sites had concurrent liver disease (20% caused by hepatitis C virus, 5% caused by hepatitis B virus and 5% were alcohol-related). …”
    Get full text
    Article
  17. 5017

    Phytochemicals Screening in Four Solvent Extractions of Pulverized Witchweed (Striga asiatica) by G. F. Kontagora, N. M. Ibrahim

    Published 2025-02-01
    “…An important finding is the significant activity of the N-hexane extract against pathogenic organisms such as Culex quinquefasciatusaa, indicating potential antifungal and antihelminthic properties. …”
    Get full text
    Article
  18. 5018

    Foxp3 Expression in Liver Correlates with the Degree but Not the Cause of Inflammation by Matthaios Speletas, Nikoletta Argentou, Georgios Germanidis, Themistoclis Vasiliadis, Konstantinos Mantzoukis, Kalliopi Patsiaoura, Pavlos Nikolaidis, Vaios Karanikas, Konstantinos Ritis, Anastasios E. Germenis

    Published 2011-01-01
    “…Patients with chronic viral hepatitis display increased expression of Foxp3 in liver, suggesting that Tregs expansion contributes to persistent infection. …”
    Get full text
    Article
  19. 5019

    Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models by Ali Mahmoudi, Seyed Adel Moallem, Thomas P. Johnston, Amirhossein Sahebkar

    Published 2022-01-01
    “…Fenofibrate is a fibrate drug approved for dyslipidemia that could be used for modulation of hepatic fat accumulation, targeting peroxisome proliferator-activator receptors, and de novo lipogenesis. …”
    Get full text
    Article
  20. 5020

    الأرشفة الالکترونیة للأطروحات العلمیة فی مکتبات جامعات مکة المکرمة والمدینة المنورة : دراسة وصفیة تحلیلیة... by د. عبد الرحمن غالب دبور

    Published 2016-01-01
    “…The results show that the project of e-achieving began first in the libraryof Islamic university in the year 1426 (Hejri), we find that the Om Al Qurauniversity had started to Electronic Archiving project in the year 1427 (Hejri), andthe project of e-achieving of Taibah university began in the year 1431 (Hejri)where the project for both of these universities are library staff for each university.The study found the motive of the application of the e-archiving in the University.The evolution of the systems, including the mechanism in the area of Librariesand Information Sciences, the demand of the beneficiaries, and then to be madeavailable online through the Internet and providing time and effort. …”
    Get full text
    Article